logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Patrick Vermersch

Lille University Hospital
H指数:72
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

DELPHI expert consensus-derived factors influencing the early use of monoclonal high-efficacy therapies in treatment-naïve patients with relapsing-remitting multiple sclerosis

德尔菲专家共识中影响复发缓解型多发性硬化治疗初治患者早期使用高效单克隆疗法的影响因素

Journal of Neurology
IF4.6
2026-10-220
OAAI
Bertrand Bourre; Olivier Guerrier; Xavier Ayrignac; Laurent Suchet; Jérôme de Seze; Ines Masmoudi; Vito A. G. Ricigliano; Patrick Vermersch; Jonathan Ciron
Use of patient reported outcomes in multiple sclerosis clinical management: Scoping literature review

在多发性硬化临床管理中使用患者报告结果：范围性文献综述

Multiple Sclerosis Journal
IF5
2026-09-290
PRE
Maja Kuharic; Cindy Nowinski; Chelsea R. Perschon; Corinne H. Miller; Mohsharif Nasrulloeva; Robert Hyde; Paul Kamudoni; Iris-Katharina Penner; Per S. Sorensen; Jaume Sastre-Garriga; Aksel Siva; Christine Lebrun-Frenay; Angela White; Helga Weiland; Paola Zaratin; Patrick Vermersch; Magaly Tourtelier-Girard; Gilles Edan; Gary Cutter; Jeremy Hobart; David Cella; Robert McBurney;
A clustering-based approach to characterize autonomy profiles among multiple sclerosis patients: an application of the Qluster method in the FOCAL-MS2 study

基于聚类的多发性硬化患者自主性特征研究：Qluster方法在FOCAL-MS2研究中的应用

Journal of Patient-Reported Outcomes
IF2.9
2026-05-010
PRE
Pau, David; Civet, Alexandre; Donze, Cecile; Paillot, Geraud; Mekies, Claude; Cohen, Mikael; Brechenmacher, Lucie; Mouzawak, Catherine; Vermersch, Patrick; Esnault, Cyril; Le Ralle, Svetlana
Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

克拉屈滨在复发型多发性硬化中的临床和机制性作用：MAGNIFY-MS研究2年结果

Therapeutic Advances in Neurological Disorders
IF4.1
2025-07-310
OA
Klaus Schmierer; Heinz Wiendl; Frederik Barkhof; Xavier Montalban; Anat Achiron; Tobias Derfuss; Andrew Chan; Suzanne Hodgkinson; Alexandre Prat; Letizia Leocani; Finn Sellebjerg; Patrick Vermersch; Hulin Jin; Laura Sponton; Anita Chudecka; Lidia Gardner; Nicola De Stefano
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study

研究总结：接受克拉屈滨片治疗复发型多发性硬化患者的血液生物标志物动态变化：MAGNIFY-MS研究2年结果

Neurology and Therapy
IF4.8
2025-07-040
OAAI
Heinz Wiendl; Frederik Barkhof; Xavier Montalban; Anat Achiron; Tobias Derfuss; Andrew Chan; Suzanne Hodgkinson; Alexandre Prat; Letizia Leocani; Klaus Schmierer; Finn Sellebjerg; Patrick Vermersch; Hulin Jin; Anita Chudecka; Andreas Kloetgen; Dongdong Lin; Lidia Gardner; Nicola De Stefano
Tyrosine kinase inhibitor, masitinib, limits neuronal damage, as measured by serum neurofilament light chain concentration in a model of neuroimmune-driven neurodegenerative disease

酪氨酸激酶抑制剂masitinib可限制神经损伤，如通过血清神经丝轻链浓度测量的神经免疫驱动型神经退行性疾病模型所示。

PLOS ONE
IF2.6
2025-05-140
OA
Hermine, Olivier; Gros, Laurent; Tran, Truong-An; Loussaief, Lamya; Flosseau, Kathleen; Moussy, Alain; Mansfield, Colin D.; Vermersch, Patrick
LymphoTEC: a Retrospective Real-World Study on Lymphocyte Reconstitution After Lymphopenia in Patients with Multiple Sclerosis Treated with Dimethyl Fumarate in France
ADVANCES IN THERAPY
IF4
2025-02-190
OAAI
de Seze, Jerome; Labauge, Pierre; Liblau, Roland; Martinez, Mikel; Moreau, Thibault; Suchet, Laurent; Vermersch, Patrick; Vukusic, Sandra; Mathey, Guillaume; Michel, Laure; Ciron, Jonathan; Ruet, Aurelie; Maillart, Elisabeth; Zephir, Helene; Papeix, Caroline; Defer, Gilles; Cohen, Mikael; Laplaud, David Axel; Berger, Eric; Clavelou, Pierre; Thouvenot, Eric; Heinzlef, Olivier; Pelletier, Jean; Giannesini, Claire; Casez, Olivier; Bourre, Bertrand; Wahab, Abir; Magy, Laurent; Camdessanche, Jean-Philippe; Doghri, Ines; Labeyrie, Celine; Hankiewicz, Karolina; Neau, Jean-Philippe; Pottier, Corinne; Dobay, Pamela; Li, Hanyue; Levin, Seth; Gros, Marilyn; Ruiz, Marta; Rollot, Fabien
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

克拉屈滨片治疗复发性多发性硬化症患者的血液生物标志物动态: 2年MAGNIFY-MS研究结果

FRONTIERS IN IMMUNOLOGY
IF5.9
2025-02-030
OAAI
Wiendl, Heinz; Barkhof, Frederik; Montalban, Xavier; Achiron, Anat; Derfuss, Tobias; Chan, Andrew; Hodgkinson, Suzanne; Prat, Alexandre; Leocani, Letizia; Schmierer, Klaus; Sellebjerg, Finn; Vermersch, Patrick; Jin, Hulin; Chudecka, Anita; Kloetgen, Andreas; Lin, Dongdong; Gardner, Lidia; De Stefano, Nicola
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
IF7.5
2024-09-011
OAAI
Lin, Ting-Yi; Motamedi, Seyedamirhosein; Asseyer, Susanna; Chien, Claudia; Saidha, Shiv; Calabresi, Peter A.; Fitzgerald, Kathryn C.; Samadzadeh, Sara; Villoslada, Pablo; Llufriu, Sara; Green, Ari J.; Preiningerova, Jana Lizrova; Petzold, Axel; Leocani, Letizia; Garcia-Martin, Elena; Oreja-Guevara, Celia; Outteryck, Olivier; Vermersch, Patrick; Balcer, Laura J.; Kenney, Rachel; Albrecht, Philipp; Aktas, Orhan; Costello, Fiona; Frederiksen, Jette; Uccelli, Antonio; Cellerino, Maria; Frohman, Elliot M.; Frohman, Teresa C.; Bellmann-Strobl, Judith; Schmitz-Huebsch, Tanja; Ruprecht, Klemens; Brandt, Alexander U.; Zimmermann, Hanna G.; Paul, Friedemann

研究方向

暂未获取到该数据
J
J. de Sèze
H 指数:86论文数:1,097被引数:3.7万
H
Hélène Zéphir
H 指数:56论文数:336被引数:9,875
G
Gavin Giovannoni
H 指数:104论文数:1,308被引数:4.2万
O
Olivier Outteryck
H 指数:38论文数:145被引数:6,414
P
Per Soelberg Sørensen
H 指数:95论文数:724被引数:4.9万
C
Christine Lebrun‐Frénay
H 指数:68论文数:683被引数:1.6万
P
Peter Rieckmann
H 指数:75论文数:414被引数:1.8万
X
Xavier Montalbán
H 指数:126论文数:1,357被引数:8.9万
G
Gıancarlo Comı
H 指数:120论文数:1,290被引数:6.3万
K
Kottil Rammohan
H 指数:43论文数:207被引数:1.2万